 3. Females must be surgically sterile or at least 2 years postmenopausal, or if of childbearing potential, have a negative screening urine pregnancy test and be willing to practice sexual abstinence or use an accepted form of contraception with her partner for example, barrier or hormonal methods during treatment and for at least 28 days after the last dose of study drug. 